LY293111

DRUG3 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Eli Lilly and Company

Conditions

Carcinoma, Non-Small-Cell LungPancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

LY293111 in Treating Patients With Advanced Solid Tumors

CompletedNCT00006375

Memorial Sloan Kettering Cancer CenterUnspecified Adult Solid Tumor, Protocol Specific

Start: 2000-06-30End: 2003-02-28Updated: 2013-06-18

Phase 2

A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

CompletedNCT00055250

Eli Lilly and CompanyPancreatic Cancer

Start: 2003-01-31End: 2005-10-31Target: 130Updated: 2007-01-26

A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer

CompletedNCT00069875

Eli Lilly and CompanyCarcinoma, Non-Small-Cell Lung

Start: 2003-09-30End: 2005-12-31Target: 195Updated: 2007-12-21